191 related articles for article (PubMed ID: 11972058)
1. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of CK2 during the progression of cell cycle.
Homma MK; Homma Y
Mol Cell Biochem; 2005 Jun; 274(1-2):47-52. PubMed ID: 16335528
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E
Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717
[TBL] [Abstract][Full Text] [Related]
4. Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation.
Fagman H; Larsson F; Arvidsson Y; Meuller J; Nordling M; Martinsson T; Helmbrecht K; Brabant G; Nilsson M
Oncogene; 2003 Sep; 22(38):6013-22. PubMed ID: 12955080
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis.
Channavajhala P; Seldin DC
Oncogene; 2002 Aug; 21(34):5280-8. PubMed ID: 12149649
[TBL] [Abstract][Full Text] [Related]
6. Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue origin.
Dihlmann S; Amler LC; Schwab M; Wenzel A
Oncol Res; 1997; 9(3):119-27. PubMed ID: 9220497
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
8. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
Lebrin F; Chambaz EM; Bianchini L
Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains.
Li Z; Näthke IS
Cancer Res; 2005 Jun; 65(12):5195-204. PubMed ID: 15958564
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.
Bhattacharya G; Boman BM
Biochem Biophys Res Commun; 1995 Mar; 208(1):103-10. PubMed ID: 7887918
[TBL] [Abstract][Full Text] [Related]
12. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
Rubinfeld B; Albert I; Porfiri E; Munemitsu S; Polakis P
Cancer Res; 1997 Oct; 57(20):4624-30. PubMed ID: 9377578
[TBL] [Abstract][Full Text] [Related]
13. APC binds to the novel protein EB1.
Su LK; Burrell M; Hill DE; Gyuris J; Brent R; Wiltshire R; Trent J; Vogelstein B; Kinzler KW
Cancer Res; 1995 Jul; 55(14):2972-7. PubMed ID: 7606712
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2.
Romero-Oliva F; Jacob G; Allende JE
J Cell Biochem; 2003 May; 89(2):348-55. PubMed ID: 12704797
[TBL] [Abstract][Full Text] [Related]
15. Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3.
Ferrarese A; Marin O; Bustos VH; Venerando A; Antonelli M; Allende JE; Pinna LA
Biochemistry; 2007 Oct; 46(42):11902-10. PubMed ID: 17910481
[TBL] [Abstract][Full Text] [Related]
16. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.
Messenger MM; Saulnier RB; Gilchrist AD; Diamond P; Gorbsky GJ; Litchfield DW
J Biol Chem; 2002 Jun; 277(25):23054-64. PubMed ID: 11940573
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor gene product APC is hyperphosphorylated during the M phase.
Bhattacharjee RN; Hamada F; Toyoshima K; Akiyama T
Biochem Biophys Res Commun; 1996 Mar; 220(1):192-5. PubMed ID: 8602842
[TBL] [Abstract][Full Text] [Related]
18. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
19. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
20. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.
Kohler EM; Derungs A; Daum G; Behrens J; Schneikert J
Hum Mol Genet; 2008 Jul; 17(13):1978-87. PubMed ID: 18387968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
